Related Experiment Videos
[Hemorrhagic shock and encephalopathy syndrome]
1Vestische Kinderklinik, Datteln.
Summary
Hemorrhagic shock and encephalopathy syndrome (HSES) is a severe condition with unknown causes. Early treatment of complications like brain edema and shock may improve outcomes for affected children.
Area of Science:
- Pediatric Neurology
- Critical Care Medicine
- Clinical Research
Background:
- Hemorrhagic shock and encephalopathy syndrome (HSES) is likely underreported in Germany.
- Further case observations are needed to understand HSES incidence and characteristics.
Observation:
- Seven pediatric patients (8 days to 9.5 months) diagnosed with HSES between 1987-1992 were evaluated.
- Clinical data and laboratory findings were systematically assessed.
Findings:
- All patients presented with disturbed consciousness, severe shock, metabolic acidosis, fever, and coagulation abnormalities.
- Diarrhea preceded HSES in some cases; brain edema, cerebral infarction, or hemorrhage occurred in affected children.
- Low alpha-1-antitrypsin levels were noted in two patients during the acute phase.
Implications:
- HSES is an acute, severe clinical entity with a high mortality and morbidity rate.
- Prompt management of brain edema, shock, and disseminated intravascular coagulation is crucial for improving HSES prognosis.
- Understanding HSES etiology and risk factors is essential for developing targeted interventions.